CBD and THC Together Suppress Viral Immune Receptor Signaling More Than Either Alone
A 1:1 combination of CBD and THC (mimicking Sativex) suppressed TLR7/8-mediated inflammatory signaling in human immune cells more effectively than either cannabinoid alone.
Quick Facts
What This Study Found
TLR7/8 activation in macrophages and PBMCs promoted production of CXCL10, TNFα, and type I interferons through NF-κB, p38 MAPK, and IRF7 pathways. CBD and THC individually reduced these inflammatory mediators, but the 1:1 combination was most effective at dampening TLR7/8-induced inflammation in both cell types.
Key Numbers
1:1 CBD:THC ratio (mimicking Sativex/nabiximols formulation). Measured CXCL10, TNFα, type I IFNs. Assessed NF-κB activation, p38 MAPK phosphorylation, IRF7 transcription. Tested in both macrophage cell line and primary human PBMCs.
How They Did This
In vitro study using THP-1-derived macrophages and primary PBMCs from healthy donors. CL075 used as TLR7/8 agonist. CBD and THC tested alone and in 1:1 combination at multiple concentrations. Measured cytokines, chemokines, interferons, and signaling pathway activation.
Why This Research Matters
TLR7/8 are key sensors for viral infections and are implicated in autoimmune diseases. Showing that cannabinoids can modulate these pathways suggests potential therapeutic applications for viral inflammation and autoimmune conditions.
The Bigger Picture
This study provides mechanistic evidence for why combination cannabinoid products like Sativex might have anti-inflammatory properties beyond pain relief. The entourage effect between CBD and THC appears to extend to immune modulation.
What This Study Doesn't Tell Us
In vitro study — cell culture results may not translate to whole-organism effects. Concentrations used may not reflect achievable tissue levels. Healthy donor PBMCs may respond differently than cells from patients with autoimmune conditions.
Questions This Raises
- ?Would this immune modulation be beneficial or harmful during active viral infections?
- ?Could cannabinoid-based TLR7/8 modulation help in autoimmune diseases?
Trust & Context
- Key Stat:
- Evidence Grade:
- Well-designed in vitro study with multiple cell models, but lacks in vivo validation and clinical relevance is uncertain.
- Study Age:
- 2025 publication.
- Original Title:
- A 1:1 combination of cannabidiol and Δ9-tetrahydrocannabinol inhibit toll-like receptor 7- and 8-mediated inflammation in human immune cells.
- Published In:
- European journal of pharmacology, 1003, 177878 (2025)
- Database ID:
- RTHC-07748
Evidence Hierarchy
Frequently Asked Questions
Do CBD and THC affect the immune system?
This study showed both CBD and THC can suppress inflammatory signaling through TLR7/8 viral immune receptors in human immune cells. The combination was more effective than either alone, suggesting synergistic immune-modulating effects.
Could cannabis help with autoimmune diseases?
This lab study found cannabinoids suppress TLR7/8 signaling involved in autoimmune disease. However, this is early-stage cell culture research and does not yet prove clinical benefit for autoimmune conditions.
Read More on RethinkTHC
- CBD-oil-quality-guide
- anxiety-medication-after-quitting-weed
- cannabis-chemotherapy-nausea
- cannabis-chronic-pain-research
- cannabis-epilepsy-CBD-Epidiolex
- cbd-anxiety-research-evidence
- cbd-for-weed-withdrawal
- cbd-vs-thc-difference
- medical-benefits-of-cannabis
- quitting-weed-before-surgery
- quitting-weed-medication-interactions
- quitting-weed-pregnancy
- quitting-weed-pregnant
- seniors-older-adults-cannabis-risks-medications
- weed-breastfeeding-THC-breast-milk
Cite This Study
https://rethinkthc.com/research/RTHC-07748APA
Sun, Melody Cui; Hackett, Becky; Otálora-Alcaraz, Almudena; Downer, Eric J. (2025). A 1:1 combination of cannabidiol and Δ9-tetrahydrocannabinol inhibit toll-like receptor 7- and 8-mediated inflammation in human immune cells.. European journal of pharmacology, 1003, 177878. https://doi.org/10.1016/j.ejphar.2025.177878
MLA
Sun, Melody Cui, et al. "A 1:1 combination of cannabidiol and Δ9-tetrahydrocannabinol inhibit toll-like receptor 7- and 8-mediated inflammation in human immune cells.." European journal of pharmacology, 2025. https://doi.org/10.1016/j.ejphar.2025.177878
RethinkTHC
RethinkTHC Research Database. "A 1:1 combination of cannabidiol and Δ9-tetrahydrocannabinol..." RTHC-07748. Retrieved from https://rethinkthc.com/research/sun-2025-a-11-combination-of
Access the Original Study
Study data sourced from PubMed, a service of the U.S. National Library of Medicine, National Institutes of Health.
This study breakdown was produced by the RethinkTHC research team. We analyze and report published research findings without making health recommendations. All interpretations are based solely on the published abstract and study data.